Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases
Pablo García-Pavía
1, 2, 3
,
Claudio Rapezzi
4, 5
,
Yehuda Adler
6
,
Michael Arad
7
,
Cristina Basso
3, 8
,
Antonio Brucato
9
,
Ivana Burazor
10
,
A. L. P. CAFORIO
3, 11
,
Thibaud Damy
12
,
U Erikkson
13
,
Marianna Fontana
14
,
Julian D. Gillmore
14
,
Esther Gonzalez-Lopez
1, 3
,
Martha Grogan
15
,
Stephane Heymans
16, 17, 18
,
Massimo Imazio
19
,
Ingrid Kindermann
20
,
Arnt V Kristen
21, 22
,
Mathew S. Maurer
23
,
G Merlini
24, 25
,
Antonis Pantazis
26
,
Sabine Pankuweit
27
,
Angelos G. Rigopoulos
28
,
Ales Linhart
29
1
3
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart‐ERN GUARD‐Heart
6
9
10
12
French Referral Centre for Cardiac Amyloidosis, Amyloidosis Mondor Network GRC Amyloid Research Institute, CHU Henri Mondor Créteil France
|
19
University Cardiology, Cardiovascular and Thoracic Department, AOU Città della Salute e della Scienza di Torino Turin Italy
|
22
Cardiovascular Centre Darmstadt Heidelberg Germany
|
23
26
Cardiomyopathy Service Royal Brompton Hospital London UK
|
Publication type: Journal Article
Publication date: 2021-04-07
scimago Q1
wos Q1
SJR: 5.559
CiteScore: 22.0
Impact factor: 10.8
ISSN: 13889842, 18790844
PubMed ID:
33826207
Cardiology and Cardiovascular Medicine
Abstract
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
|
|
|
European Journal of Heart Failure
21 publications, 7.58%
|
|
|
Frontiers in Cardiovascular Medicine
11 publications, 3.97%
|
|
|
Journal of Clinical Medicine
10 publications, 3.61%
|
|
|
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
9 publications, 3.25%
|
|
|
ESC heart failure
8 publications, 2.89%
|
|
|
European Heart Journal
7 publications, 2.53%
|
|
|
International Journal of Cardiology
7 publications, 2.53%
|
|
|
Journal of Cardiovascular Medicine
6 publications, 2.17%
|
|
|
Biomedicines
6 publications, 2.17%
|
|
|
American Journal of Cardiology
6 publications, 2.17%
|
|
|
Cureus
5 publications, 1.81%
|
|
|
Journal of Nuclear Cardiology
4 publications, 1.44%
|
|
|
JACC Advances
4 publications, 1.44%
|
|
|
Current Problems in Cardiology
4 publications, 1.44%
|
|
|
European Heart Journal Cardiovascular Imaging
4 publications, 1.44%
|
|
|
Archives of Cardiovascular Diseases
4 publications, 1.44%
|
|
|
Heart Failure Clinics
4 publications, 1.44%
|
|
|
Revista Espanola de Cardiologia
3 publications, 1.08%
|
|
|
Diagnostics
3 publications, 1.08%
|
|
|
REC: CardioClinics
3 publications, 1.08%
|
|
|
Vessel Plus
3 publications, 1.08%
|
|
|
Journal of Nuclear Medicine
2 publications, 0.72%
|
|
|
Life
2 publications, 0.72%
|
|
|
Herz
2 publications, 0.72%
|
|
|
Advances in Therapy
2 publications, 0.72%
|
|
|
Medicina Clínica (English Edition)
2 publications, 0.72%
|
|
|
JACC: Cardiovascular Interventions
2 publications, 0.72%
|
|
|
Medicina Clinica
2 publications, 0.72%
|
|
|
Revista Portuguesa de Cardiologia
2 publications, 0.72%
|
|
|
5
10
15
20
25
|
Publishers
|
10
20
30
40
50
60
70
80
|
|
|
Elsevier
78 publications, 28.16%
|
|
|
Springer Nature
44 publications, 15.88%
|
|
|
Wiley
36 publications, 13%
|
|
|
MDPI
27 publications, 9.75%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
17 publications, 6.14%
|
|
|
Taylor & Francis
15 publications, 5.42%
|
|
|
Oxford University Press
14 publications, 5.05%
|
|
|
Frontiers Media S.A.
13 publications, 4.69%
|
|
|
OAE Publishing Inc.
3 publications, 1.08%
|
|
|
Sociedade Brasileira de Cardiologia
3 publications, 1.08%
|
|
|
Society of Nuclear Medicine
2 publications, 0.72%
|
|
|
Georg Thieme Verlag KG
2 publications, 0.72%
|
|
|
SAGE
2 publications, 0.72%
|
|
|
BMJ
2 publications, 0.72%
|
|
|
IMR Press
2 publications, 0.72%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.36%
|
|
|
American College of Physicians
1 publication, 0.36%
|
|
|
Sociedade Portuguesa De Cardiologia
1 publication, 0.36%
|
|
|
Edizioni Minerva Medica
1 publication, 0.36%
|
|
|
The Korean Society of Cardiology
1 publication, 0.36%
|
|
|
IntechOpen
1 publication, 0.36%
|
|
|
Remedium, Ltd.
1 publication, 0.36%
|
|
|
American Roentgen Ray Society
1 publication, 0.36%
|
|
|
South Florida Publishing LLC
1 publication, 0.36%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.36%
|
|
|
The Japanese Circulation Society
1 publication, 0.36%
|
|
|
China Science Publishing & Media
1 publication, 0.36%
|
|
|
American Chemical Society (ACS)
1 publication, 0.36%
|
|
|
Sociedad Brasileira De Cardiologia
1 publication, 0.36%
|
|
|
10
20
30
40
50
60
70
80
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
277
Total citations:
277
Citations from 2024:
140
(50.54%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
García-Pavía P. et al. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases // European Journal of Heart Failure. 2021. Vol. 23. No. 4. pp. 512-526.
GOST all authors (up to 50)
Copy
García-Pavía P., Rapezzi C., Adler Y., Arad M., Basso C., Brucato A., Burazor I., CAFORIO A. L. P., Damy T., Erikkson U., Fontana M., Gillmore J. D., Gonzalez-Lopez E., Grogan M., Heymans S., Imazio M., Kindermann I., Kristen A. V., Maurer M. S., Merlini G., Pantazis A., Pankuweit S., Rigopoulos A. G., Linhart A. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases // European Journal of Heart Failure. 2021. Vol. 23. No. 4. pp. 512-526.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1002/ejhf.2140
UR - https://doi.org/10.1002/ejhf.2140
TI - Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases
T2 - European Journal of Heart Failure
AU - García-Pavía, Pablo
AU - Rapezzi, Claudio
AU - Adler, Yehuda
AU - Arad, Michael
AU - Basso, Cristina
AU - Brucato, Antonio
AU - Burazor, Ivana
AU - CAFORIO, A. L. P.
AU - Damy, Thibaud
AU - Erikkson, U
AU - Fontana, Marianna
AU - Gillmore, Julian D.
AU - Gonzalez-Lopez, Esther
AU - Grogan, Martha
AU - Heymans, Stephane
AU - Imazio, Massimo
AU - Kindermann, Ingrid
AU - Kristen, Arnt V
AU - Maurer, Mathew S.
AU - Merlini, G
AU - Pantazis, Antonis
AU - Pankuweit, Sabine
AU - Rigopoulos, Angelos G.
AU - Linhart, Ales
PY - 2021
DA - 2021/04/07
PB - Wiley
SP - 512-526
IS - 4
VL - 23
PMID - 33826207
SN - 1388-9842
SN - 1879-0844
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_García-Pavía,
author = {Pablo García-Pavía and Claudio Rapezzi and Yehuda Adler and Michael Arad and Cristina Basso and Antonio Brucato and Ivana Burazor and A. L. P. CAFORIO and Thibaud Damy and U Erikkson and Marianna Fontana and Julian D. Gillmore and Esther Gonzalez-Lopez and Martha Grogan and Stephane Heymans and Massimo Imazio and Ingrid Kindermann and Arnt V Kristen and Mathew S. Maurer and G Merlini and Antonis Pantazis and Sabine Pankuweit and Angelos G. Rigopoulos and Ales Linhart},
title = {Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases},
journal = {European Journal of Heart Failure},
year = {2021},
volume = {23},
publisher = {Wiley},
month = {apr},
url = {https://doi.org/10.1002/ejhf.2140},
number = {4},
pages = {512--526},
doi = {10.1002/ejhf.2140}
}
Cite this
MLA
Copy
García-Pavía, Pablo, et al. “Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology W orking G roup on M yocardial and P ericardial D iseases.” European Journal of Heart Failure, vol. 23, no. 4, Apr. 2021, pp. 512-526. https://doi.org/10.1002/ejhf.2140.